We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App




Osteopontin and Osteoprotegerin Investigated In Peripheral Artery Disease

By LabMedica International staff writers
Posted on 08 Sep 2022

Peripheral artery disease (PAD) is one of the many complications of systemic atherosclerosis and it is accompanied by high rates of cardiovascular diseases (CVD) morbidity and mortality. More...

PAD is a common condition in which narrowed arteries reduce blood flow to the arms or legs.

Atherosclerosis is a complex procedure of different pathways. Among other cytokines, inflammation and calcification are known to be regulated also by well-known bone regulators, such as osteoprotegerin (OPG) and osteopontin (OPN). OPG is a secretory basic glycoprotein and a member of the tumor necrosis factor (TNF) receptor superfamily, acting as an inhibitor of bone resorption. OPN is a highly phosphorylated glycophosphoprotein having acidic characteristics and rich in aspartic acid.

Clinical Scientists at the Medical School University of Cyprus (Nicosia, Cyprus) and their colleagues enrolled 203 consecutive patients with symptomatic, established PAD requiring endovascular revascularization (percutaneous transluminal angioplasty–PTA and/or stent placement) of any or both of their lower limbs (PAD group–PADG). They also recruited 78 age- and sex-matched subjects with less than two classical cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, smoking, family history of premature CAD) who served as control group (COG).

Overnight fasting, blood samples were obtained and glycemic and lipid parameters were immediately assayed in an AU560 automatic enzymatic analyzer (Olympus, Hamburg, Germany). The glycated hemoglobin (HbA1c) was determined by high-performance liquid chromatography (Menarini Diagnostics, Florence, Italy) only in diabetic patients. Serum OPN and OPG were assayed using quantikine immunoassay EIA kits (R&D Systems Inc., Minneapolis, MN, USA) and Metra, San Diego, CA, USA). The high-sensitivity C-Reactive Protein (hsCRP) levels were measured with latex-enhanced immunonephelometry (Dade Behring, Marburg, Germany).

The investigators reported that during 12-month follow-up, 82 major adverse cardiovascular events (MACE) were recorded (MACE subgroup). The rest of 124 PAD patients remained free of MACE (non-MACE subgroup). At baseline, OPG (9.89 ± 2.85 ng/mL versus 3.47 ± 1.95 ng/mL) and OPN (79.99 ± 38.29 ng/mL versus 35.21 ± 14.84 ng/mL) levels were significantly higher in PADG compared to COG, as well as in MACE subgroup compared to non-MACE subgroup (13.29 ± 3.23 ng/mL versus 10.86 ± 3 ng/mL and 96.45 ± 40.12 ng/mL versus 78.1 ± 38.29 ng/mL, respectively). An independent association of PAD with OPG and OPN was found in the whole patient cohort.

The authors concluded that baseline high OPG and OPN levels were independently associated with the presence of PAD. Even higher levels of those biomarkers were detected among PAD patients with MACE. The study was published on September 1, 2022 in the journal Cardiovascular Diabetology.

Related Links:
Medical School University of Cyprus
Olympus 
Menarini Diagnostics 
R&D Systems Inc 
Metra 
Dade Behring 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.